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174Objective: Systemic cooling for cardiopulmonary bypass is widely used to attenuate the systemic inflammatory
response syndrome and organ injury in children after open surgery. We compared the effects of moderate (24C)
and mild (34C) hypothermia during bypass on markers of the systemic inflammatory response syndrome and
organ injury, and on clinical outcome after corrective surgery for congenital heart disease.
Methods: Sixty-six children (mean age, 6.8 5.7 months; mean weight, 6.2 2.3 kg) were randomized to 24C
or 34C bypass temperature during cardiac surgery. Perfusion strategies were otherwise strictly identical.
Clinical data and blood samples were collected before bypass, 5 minutes after aortic crossclamp release, and
4, 24, and 48 hours after bypass. Patients were followed up until discharge from the hospital.
Results: In the 54 children with outcome data, bypass temperature did not influence the duration of mechanical
ventilation between the 24C group and the 34C group (median [interquartile range] 22 [13–40] hours vs 14
[8–40] hours, P ¼ .14), intensive care unit stay (43 [24–49] hours vs 29 [23–47] hours, P ¼ .79), blood loss
(29 [20–38] mL/kg vs 23 [13–38] mL/kg, P ¼ .36), or incidence of postoperative infection (9% vs 11%,
P ¼ 1.0). There was no evidence of an influence of bypass temperature on the markers of acute inflammation,
innate immune response, organ injury, coagulation, or hemodynamics.
Conclusions: There is no evidence that the systemic inflammatory response syndrome and organ injury after
pediatric open surgery are influenced by bypass temperature. The routine use of hypothermic bypass may not
be warranted in the pediatric population. (J Thorac Cardiovasc Surg 2011;142:174-80)Cardiopulmonary bypass (CPB) used for adult cardiac sur-
gery is now uniformly carried out under normothermic condi-
tions. The temperatures applied in pediatric CPB vary
significantly, ranging from deep hypothermia to normother-
mia. The lack of a consistent approach to CPB temperature
in pediatric practice is related to a lack of supportive evidence
from well-designed randomized trials.1,2 This prospective,
randomized, blinded study compared the effects of mild
(34C) and moderate hypothermia (24C) during CPB
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The Journal of Thoracic and Cardiovascular Surgresponse syndrome (SIRS), and the development of posto-
perative organ injury in a group of infants and children
undergoing open surgery.MATERIAL AND METHODS
Enrollment of Patients
This trial was approved by the Human Research Ethics Committee of
The Royal Children’s Hospital (RCH), Melbourne. Written informed con-
sent was obtained from the parents before the surgery. Term neonates, in-
fants, and children with body weight up to 12 kg undergoing elective
corrective surgery for congenital heart disease on CPB were considered
for inclusion. Excluded were patients with suspected or proven infection,
the likely need for intraoperative deep hypothermia, requirement of me-
chanical ventilation (MV) within 48 hours before surgery, and CPB surgery
within the preceding 6 months.
Study Design
This randomized study was performed in the operating theaters and pe-
diatric intensive care unit at the RCH. Participants were randomized to
a body temperature of either 24C or 34C during CPB.With the exception
of the perfusionist undertaking the case, none of the other treating clini-
cians or investigators were made aware as to the group allocation before
data analysis. However, because the surgeon had direct contact with the pa-
tient during CPB, it was likely that he would have deduced the group allo-
cation from the temperature of the tissues and blood during surgery. The
study commenced with baseline measurements and blood sampling after
induction of anesthesia before the onset of CPB. Further measurements
were obtained 5 minutes after release of the aortic crossclamp and 4, 24,
and 48 hours after separation from CPB.ery c July 2011
TABLE 1. Patient characteristics
24C (n ¼ 27) 34C (n ¼ 27)
Age (d), mean (SD) 185.2  165.4 223.6  175.7
Male gender, n (%) 16 (59%) 16 (59%)
Weight (kg), mean (SD) 6.15  2.48 6.37  2.37
Diagnosis, n
AVSD 11 12
Tetralogy of Fallot 6 8
Pulmonary atresia
VSD 1 1
IVS 2 0
D-TGA
VSD 4 1
IVS 3 3
TAPVD 0 1
Truncus arteriosus 0 1
SD, Standard deviation; AVSD, atrioventricular septal defect; IVS, intact ventricular
septum; D-TGA, D-transposition of the great arteries; TAPVR, total anomalous pul-
monary venous return.
TABLE 2. Baseline measurements (pre-cardiopulmonary bypass)
24C
(n ¼ 27)
34C
(n ¼ 27)
Hemodynamic indices
Heart rate (beats/min) 128  24 124  27
Systolic arterial blood pressure (mm Hg) 84  18 76  10
Mean arterial blood pressure (mm Hg) 59  12 54  11
Diastolic arterial blood pressure (mm Hg) 43  9 41  8
Inotropic score (mg/kg/min) 0  0 0  0
Lactate (mmol/L) 1.6  0.6 1.7  1.1
Acute inflammation
Total white blood cell count (3109/L) 8.5  3.2 8.3  3.8
Immature-to-mature neutrophil ratio 0.05  0.03 0.07  0.07
C-reactive protein (mg/L) 8.6  2.6 8.7  2.7
TNF-a (hg/L) 3.7  2.9 3.9  2.2
IL-6 (hg/L) 6.9  5.7 10.4  13.7
IL-10 (hg/L) 7.3  5.1 6.9  3.2
Organ injury
Oxygenation index 4.7  3.5 3.9  3.5
Creatinine (mmol/L) 35  21 34  8
Microalbuminuria (mg/mmol) 24  43 6.4  9.4
S100B (mg/L) 0.46  0.37 0.45  0.44
Coagulation profile
Prothrombin time (s) 12.2  6.2 11.8  6.5
Activated partial
thromboplastin time (s)
47  9 48  12
Fibrinogen (g/L) 2.3  0.6 2.4  0.8
Platelet count (3109/L) 343  113 392  119
TNF, Tumor necrosis factor; IL, interleukin. Data expressed as mean  standard
deviation.
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
IL ¼ interleukin
mHLA ¼ monocyte human leucocyte antigen
MV ¼ mechanical ventilation
RCH ¼ Royal Children’s Hospital
SIRS ¼ systemic inflammatory response
syndrome
TLR ¼ toll-like receptor
TNF ¼ tumor necrosis factor
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All participants received intravenous methylprednisolone (25 mg/kg) at
induction. A single oxygenator (RX05, Terumo Corp, Tokyo, Japan) was
used for all participants, as well as our standard CPB circuit and priming
protocol. Blood was added to the prime to achieve a hematocrit of 30%.
Heparin therapy was adjusted to maintain an activated clotting time greater
than 400 seconds. Aprotinin was given in a standard dose regimen, and an
a-stat blood gas management was applied. Myocardial protection was
achieved with intermittent blood cardioplegia at 25C. Nasopharyngeal
and esophageal temperatures were measured continuously and kept within
1C of target CPB temperature. Weaning from CPB was commenced at
a nasopharyngeal temperature of 36C. All patients were treated with mod-
ified ultrafiltration to a total volume of 100 mL/kg.3-5 Weaning from MV
was managed by experienced medical staff 24 hours per day according
to predefined clinical parameters including clinical condition, blood
gases, acid-base balance, hemodynamic stability, and wakefulness.
Study Outcomes
Primary and secondary outcomes. The primary outcome of the
study was the duration of postoperative MV calculated from the time of ad-
mission to the pediatric intensive care unit after surgery. Secondary endpoints
included clinical outcomes, organ injury, hemodynamics, inotropic score,6
coagulation profile, andmarkers of inflammation.Markers of organ injury in-
cluded serum lactate, oxygenation index, creatinine, microalbuminuria, and
plasma S-100B. Inflammatory markers included tumor necrosis factor
(TNF)-a, interleukin (IL)-6 and 10, monocyte human leucocyte antigen
(mHLA)-DR, toll-like receptor (TLR)-2 and TLR-4, C-reactive protein, total
white cell count, and immature-to-total neutrophil ratio.
Statistical Analysis
The sample size calculation was based on the primary outcome of dura-
tion ofMV. Historic data on 24 neonates undergoing the arterial switch pro-
cedure at The RCH who were given prophylactic methylprednisolone
showed a geometric mean duration of MVof 40 hours with a standard de-
viation of 0.5 on the log-scale. The trial was powered to find a reduction of
12 hours in the moderate group compared with the mild group, thought to
be clinically important according to a round-table discussion of experts in
the field. A reduction from 40 to 28 hours (3.69 to 3.33 on the log-scale)
corresponds to a sample size of 33 per group (assuming a standard devia-
tion of 0.5 on the log-scale, 80% power, and 5% significance). The final
sample size of 27 per group provides 73% power to detect a difference
of 12 hours in the primary outcome and 80% power to find a difference
of 20 hours. Outcomes were compared using t tests and Wilcoxon rank-
sum tests for continuous data, and chi-square tests for categoric data using
a per protocol analysis (excluding major protocol violations) where out-
come data were available. Serial measurement outcomes were compared
using repeated-measures analysis of variance, including group-by-time in-The Journal of Thoracic and Cateraction to identify differences at specific time points where outcome data
was available. All descriptive and inferential statistics were performed us-
ing commercial software (SAS v9.1, SAS Institute Inc, Cary, NC).RESULTS
Between March 2003 and July 2005, 66 patients were re-
cruited for the study. One patient was excluded afterrdiovascular Surgery c Volume 142, Number 1 175
TABLE 3. Intraoperative characteristics
24C (n ¼ 27) 34C (n ¼ 27)
Difference in
means/medians (95% CI*) P value
CPB time (min) – median (IQR)x 141 (96–171) 106 (86–163) 35 .16y
Aortic crossclamp time (min) – mean  SDx 83  31 75  31 8 (25 to 10) .38z
Blood prime volume (mL/kg) – mean  SDx 76  38 75  35 2 (22 to 19) .87z
Time to normothermia (min) – median (IQR)x 30 (21–43) 14 (10–15) 16 <.001y
Ultrafiltration volume (mL/kg) – median (IQR)x 182 (54–364) 147 (85–318) 35 .94þ
CI, Confidence interval; CPB, cardiopulmonary bypass; IQR, interquartile range; SD, standard deviation. *Where applicable. yRank-sum P value. zt test P value. xOutcome data
available for 26 patients in the 24C arm and 25 patients in the 24C arm.
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Mrandomization because of cardiac arrest at induction of an-
esthesia. Six participants in the moderate hypothermia
(24C) and 5 patients in the mild hypothermia (34C) group
were excluded from subsequent analysis because of proto-
col violations. This included 2 patients who returned from
the operating room on extracorporeal life support, 2 patients
who required more than 1 CPB course in the same operating
session, and 7 patients in whom the surgeon chose to alter
the temperature because of change in perfusion require-
ments (low-flow CPB or circulatory arrest, 3 patients in
the moderate group and 4 patients in the mild hypothermia
group). Thus, 27 patients in each group are included in the
analysis.Baseline and Intraoperative Characteristics
Patient demographics, baseline measurements, and intra-
operative characteristics were similar in both groups. As
would be expected, mean CPB time was longer in the mod-
erate hypothermia group because of the longer period
required for rewarming from target CPB temperature to nor-
mothermia (Tables 1–3).TABLE 4. Clinical outcomes
24C
(n ¼ 27)
34C
(n ¼ 27) P
Duration of MV (h) 22 (13–40)
(n ¼ 25)
14 (8–40)
(n ¼ 25)
.14
Time on supplemental
oxygen (h)
47 (33–69)
(n ¼ 22)
47 (66–96)
(n ¼ 20)
.95
Time to removal of last
wound/chest drain (h)
44 (39–46)
(n ¼ 20)
45 (40–60)
(n ¼ 21)
.38Clinical Outcomes
The results show a tendency toward a reduction in the
median duration of MVof 8 hours in the mild hypothermia
group compared with the moderate hypothermia group
(median [interquartile range] 22 [13–40] hours at 24C
vs 14 hours [8–40] at 34C, P ¼ .14), but little evidence
of a difference in any of the other clinical outcomes
(Table 4).Total postoperative blood
loss (mL/kg)
29 (20–38)
(n ¼ 24)
23 (13–38)
(n ¼ 25)
.36
Total postoperative
transfusion (mL/kg)
20 (6–26)
(n ¼ 24)
17 (2–27)
(n ¼ 26)
.52
Delayed chest closure or
reopening (no. of patients)
0
(n ¼ 27)
0
(n ¼ 27)
Postoperative infection
(no. of patients,%)
2 (9%)
(n ¼ 27)
3 (11%)
(n ¼ 27)
.10
Stay in PICU (h) 43 (24–49)
(n ¼ 24)
29 (23–47)
(n ¼ 23)
.79
Stay in hospital (h) 145 (112–193)
(n ¼ 24)
12 (97–169)
(n ¼ 23)
.18
MV,Mechanical ventilation; PICU, pediatric intensive care unit. Values expressed as
median (interquartile range) unless otherwise specified.Markers of Inflammation
The total white cell count decreased in both groups
from baseline until crossclamp removal, with a greater de-
crease in the 24C group (overall P ¼ .04) (Figure 1).
The maximum postoperative temperature was similar in
both groups, and although an inflammatory response
was seen in both groups, there was no evidence for an in-
fluence of CPB temperature on immature-to-total neutro-
phil ratio, C-reactive protein, fibrinogen, TNF-a, IL-6, or
IL-10, or in expression of TLR-2, TLR-4, or mHLA-DR
(all P> .1).176 The Journal of Thoracic and Cardiovascular SurgHemodynamics, Markers of Organ Injury, and
Coagulation
There was no evidence of a difference in changes in heart
rate, mean arterial blood pressure, inotropic score, or serum
lactate between the 2 groups throughout the study period.
There was also no evidence of a difference in the changes
in oxygenation index, serum creatinine, microalbuminuria,
or S100B. Coagulation profiles and platelet count were sim-
ilar in both groups (all P>.1) (Figure 2).DISCUSSION
This study has addressed an important and previously un-
resolved clinical question regarding the most appropriate
temperature during pediatric CPB.2,7-9 Although moderate
hypothermia at 28C has been shown to offer better
protection from postoperative SIRS than normothermia
(37C) during CPB in the experimental setting, this has
never been shown to translate into improved outcomes in
the clinical setting.10,11 Thus, following the precedentery c July 2011
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FIGURE 1. Markers of acute inflammation. Absolute changes in markers for acute inflammation, acute phase reaction, and innate immunity from baseline
measurements; data are expressed as mean standard error. *P<.05 for differences between treatment groups. TLR-2, TLR-4, and mHLA-DR data were
only available for 8 patients in each group at each time point. The analysis used all available data. SE, Standard error;CPB, cardiopulmonary bypass; off xcl,
crossclamp off; AP, arterial pressure; TNF-a, tumor necrosis factor-a; IL, interleukin; mHLA-DR, monocyte human leucocyte antigen-DR; TLR-2/-4,
toll-like receptor 2/4; CRP, C-reactive protein; WCC, total white cell count; ITR, immature-to-total neutrophil ratio.
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FIGURE 2. Hemodynamics, markers of organ injury, and coagulation profile. Absolute changes in hemodynamic indices, markers for organ injury, and
coagulation from baseline measurements; data are expressed as mean standard error. In the 24C and 34C arms, heart rate data were missing for 15 time
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points in 16 patients, respectively; oxygenation index data were missing for 47 time points in 23 patients and 45 time points in 22 patients, respectively;
lactate data were missing for 30 time points in 18 patients and 34 time points in 20 patients, respectively; inotropic score data were missing for 9 time points
in 5 patients and 4 time points in 3 patients, respectively; creatinine data were missing for 52 time points in 16 patients and 42 time points in 15 patients,
respectively; microalbuminuria data were missing for 28 time points in 12 patients and 24 time points in 8 patients, respectively; S100B data were missing
for 6 time points in 2 patients and 5 time points in 3 patients, respectively; prothrombin time data were missing for 21 time points in 11 patients and 19 time
points in 8 patients, respectively; activated partial thromboplastin time data were missing for 21 time points in 12 patients and 22 time points in 9 patients,
respectively; and platelet count data were missing for 23 time points in 11 patients and 21 time points in 7 patients, respectively. SE, Standard error; CPB,
cardiopulmonary bypass; off xcl, crossclamp off; AP, arterial pressure; PT, prothrombin time; aPTT, activated partial thromboplastin time.
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Mfrom adult cardiac surgery, there has been a long-standing
need to reassess the role of hypothermic CPB during pedi-
atric open surgery.1,2,7,9
This study has shown that moderate hypothermia at 24C
does not offer any advantages over mild hypothermia at
34C during pediatric CPB for repair of congenital heart
disease, in terms of the postoperative clinical course and se-
verity of SIRS or markers of organ injury. Moreover, there
was a tendency toward a shorter duration of MV with mild
hypothermia. The depth of hypothermia during CPB did not
influence the risk of postoperative bleeding, blood product
transfusion requirements, or infection. As expected, there
was a trend toward a shorter duration of CPB in the mildly
hypothermic group, although this was related to the shorter
duration of the rewarming period.
When considering the biochemical and cellular manifesta-
tions of inflammation, CPB resulted in a marked acute phase
reaction in all children, but this was not influenced by temper-
ature. In keeping with our previous observations and those of
others, CPB also resulted in activation of the toll-like receptor
pathways (TLR-2, TLR-4) and in deactivation of circulating
monocytes (mHLA-DR).12,13 However, these markers were
not influenced by the temperature during CPB. We were
particularly interested to find that TNF-a, a proinflammatory
mediator that is widely proposed as an important factor
leading to the inflammatory response to CPB,14 was not influ-
enced by CPB in either group. This may in part reflect our
institutional perfusion protocol that includes some anti-
inflammatory strategies, including steroid administration and
modified ultrafiltration.
Hypothermia has been widely used in clinical practice
to offer organ protection when perfusion may be jeopar-
dized. Hypothermia has been applied during open surgery
with the aim of providing organ protection for approxi-
mately 50 years.15 In our study, we did not observe any
difference in any clinical or biochemical markers of end-
organ injury between the 2 study groups. This observation
is consistent with the findings in 2 other recent clinical tri-
als examining the effects of bypass temperature on organ
injury in pediatric open surgery.1,16 We were encouraged
that we did not observe a delayed increase of S100B,
a marker of neuronal injury, because this is thought to
correlate with brain injury and subsequent neurologic
outcome.17 As would be expected, there was postoperative
deterioration in lung and renal function, but again, this was
not influenced by the CPB temperature. Similarly, the tran-
sient microalbuminuria early after bypass indicates a sig-
nificant capillary leak, although independent of bypass
temperature.
There have been 3 other clinical investigations of the role
of hypothermic CPB in pediatric open surgery that are of
relevance.1,16,18 Caputo and colleagues1 used biochemical
and molecular markers of outcome and concluded that there
was a need for a prospective trial with clinical end points.The Journal of Thoracic and CaRasmussen and colleagues16 studied the influence of
CPB temperature only on markers of neuronal injury in
20 children, and in a recent comparison, Eggum and col-
leagues18 investigated its effects on inflammatory mediators
in 30 children. Our study is therefore unique in that we have
examined the influence of CPB temperature on markers of
inflammation, organ injury, and clinical outcome in a rela-
tively large population of infants and children. Our findings
suggest that the temperature has little effect on nonclinical
outcomes, as also suggested in these previous studies. This
conclusion is further supported by 3 large retrospective
studies confirming the feasibility, safety, and potential clin-
ical advantages of warmer CPB temperature when com-
pared with cooler CPB temperature in pediatric cardiac
surgery.8,9,19
Study Limitations
This study does, however, have a number of limitations.
First, our advanced CPB strategy, which incorporates anti-
inflammatory strategies, could theoretically have obviated
any detectable difference between our study groups. However,
because these strategies are part of routine practice in many
centers around the world, we were specifically interested in
any additional effects of temperature manipulation. Second,
the necessarily longer CPB times in the cooler group may
have negated any potential benefit from cooling. However,
the association of hypothermia and longer CPB time in our
study is consistent with previously published data, and longer
CPB time has been shown to be accompanied with enhanced
inflammatory response in pediatric cardiac surgery.1,18
Further studies determining the appropriate time to begin
rewarming to shorten bypass time are therefore warranted
with continued use of hypothermic CPB. Third, detailed
imaging and later outcome assessments would have
provided more conclusive information as to whether brain
injury had occurred. This was not practically possible at the
time of the study. Fourth, our inability to evaluate the
required sample size because of the missing data points
reduces the power of the study, increasing the risk of a type
II error. We recognize that these are both limitations of the
study; however, given that the estimates for all of the
outcomes are fairly close to 0, it is unlikely that a larger
sample size and no missing data would lead to a significant
result, and in particular one that would be clinically
important. Finally, we acknowledge that the use of aprotinin
has been abandoned in most pediatric cardiac surgical
centers since the termination of our study. Although the
use of aprotinin did not differ between study groups,
a potential influence on overall end points cannot be
excluded. It is important to note that we have not examined
‘‘normothermic’’ CPB and that our findings should not be
further extrapolated in support of this approach, with further
studies required to compare normothermia with mild
hypothermia.rdiovascular Surgery c Volume 142, Number 1 179
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MCONCLUSIONS
Postoperative SIRS and organ injury remain a problem
after pediatric open surgery. This study suggests that mod-
erate hypothermia may not offer any advantage over mild
hypothermia during CPB for pediatric cardiac surgery in
terms of clinical outcome or effect on the development of
acute inflammation or organ injury, questioning whether
moderate hypothermia may be routinely applied in this
setting.
The authors thank the Anaesthetic Research Group at the Mur-
doch Children’s Research Institute for providing the S100B Pro-
tein testing, and especially Andrew Davidson for critical review
of the article.References
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